CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Lyotropic Therapeutics, Inc. provides pharmaceutical products. The company was founded in 1999 and is headquartered in Ashland, VA.

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Changsha Daoqin Biotechnology Co., Ltd., established on 2009-07-06, Business scope includes biological products,Biological reagent research and development;additive premixed feed,Biological Reagent Sales;Manufacture of special pharmaceutical materials for environmental pollution treatment(limited branch);Application of farming technology;Veterinary drug production(limited branch);Biotechnology Consulting,communication service;Agricultural Technology Consulting,communication service;Mechanical Technology Development Services;farming,Forest,animal husbandry,Fishing Special Machinery Manufacturing(limited branch);Mechanical Technology Consulting,communication service;Packaging special equipment manufacturing(limited branch);Production of compound feed(limited branch);Concentrate supplement production(limited branch);Concentrated Feed Production(limited branch);Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Biological product production(limited branch);Biological Products Sales(limited branch);Production of biological reagents(limited branch);Veterinary drug business(limited branch);vaccine production(limited branch);Vaccine sales(limited branch);Feed additives,Additive premix feed production(limited branch).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

Nantong Zilang Biomedical Technology Co., Ltd., established on 2010-07-02, Business scope includes amino acids,Amino Acid Derivatives,nucleoside,nucleoside derivatives,Pharmaceutical Intermediates,Feed additives,Polyurethane resin,Research and technology transfer of color paste and additive production technology;Food additive production,Sales;Tryptophan,threonine,Lysine,Lysine salt,Alanine,serine,cysteine,Glycine,glutamic acid,Leucine,proline,Valine,arginine,Aspartic acid,calcium aspartate,Isoleucine,Tyrosine,cystine,Glutamine,Histidine,Glycine,Ornithine hydrochloride,(L,DL)Phenylalanine,(L,DL)Methionine,pyroglutamic acid,Theanine,calcium aspartate,BCAA Blend,Y-GABA,Ornithine-Aspartic acid,N-AcetylLTyrosine,N-Acetyl(L,DL)Methionine,N-AcetylLcysteine,Citrulline,malic acid,arginine ketoglutarate,Ornithine Ketoglutarate,Ketoglutarate,arginine-Aspartic acid,Other amino acids and amino acid derivatives,Tetraacetyl ribose,Polyurethane,Production of by-product acetic acid and sales of self-produced products;Feed additives,Pharmaceutical Intermediates,Production and sales of chemical products(Excluding hazardous chemicals);Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export)

Zhuhai Beihai Biotechnology Co., Ltd. is a company headquartered in Zhuhai, China, that operates as a clinical-stage biopharmaceutical company dedicated to development of patient-centered innovative tumor drugs with unmet clinical needs. The firm was founded in 2013 by Qun Sun.

The Chemo-Sero Therapeutic Research Institute operates as a pharmaceutical company specializing in the field of biotechnology, immunology, hematology, and microbiology. It develops and manufactures vaccines and blood plasma products. The firm's products include human and veterinary vaccines, diagnostic antigens, and treatments for congenital disorders. They also provides newborn screening tests and quality assurance systems solutions. The company was founded on December 26, 1945 and is headquartered in Kumamoto, Japan.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Kao Corp. engages in the manufacture and sale of consumer and chemical products. It operates through the following segments: Consumer Products, Chemical, and Others. The Consumer Products segment includes Cosmetics, Skin Care and Hair Care, Human Health Care, Fabric and Home Care Businesses. The Cosmetics business offers make-up products such as RMK, SUQQU, Primavista, COFFRET DOR, KATE, SENSAI, and Molton Brown. The Skin Care and Hair Care business delivers skin care products such as facial cleansers, body cleansers, sunscreens, and body lotions. It also includes hair care products such as shampoos, conditioners, and hair colors. The Human Health Care business provides sanitary products such as Laurier sanitary napkins, Merries baby diapers, Relief adult diapers, Healthya functional beverage, Clear Clean, and Deep Clean toothpastes. The Fabric and Home Care business includes Attack and Newbeads laundry detergent, Humming and Flair Fragrance fabric softener, CuCute dishwashing detergent, and Magiclean household cleaners. The Chemical segment offers oleochemicals made from natural fat and oil, performance chemicals such as surfactants, and specialty chemicals such as toners and toner binders. The Others segment handles expansion and maintenance of logistics facilities and information technology (IT)-related investments. The company was founded by Tomiro Nagase on June 19, 1887 and is headquartered in Tokyo, Japan.

Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Cellulosic Derivatives, Organic Chemicals, Plastics, Pyrotechnic Devices, and Others. The Cellulosic Derivatives segment engages in the production of various cellulosic derivatives such as cellulose acetate, acetate tow for cigarette filters, and water-soluble polymers. The Organic Chemicals segment offers various solvents and fine chemicals; acetic acid, and chiral columns used for separation of optical isomers. The Plastic segment develops unique products for numerous industrial sectors such as engineering plastics, polymer alloys and cyclic-olefin copolymers; and also develops a variety of plastic processed products such as polystyrene sheets, formed trays, and functional films. The Pyrotechnic Devices segment provides motor vehicle safety devices, airbag inflators, aerospace and defense systems. The Others segment includes membrane and warehousing business. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.

V��zkumn�� ��stav organick��ch synt��z as (doing business as VUOS AS), a subsidiary of Ameropa Holding AG, is a Czech company located in Rybitvi that provides research & development services for chemistry industry, manufactures and supplies chemical substances.

Mitsui Chemicals, Inc. manufactures and sells petrochemicals and industrial inorganic chemical products. It operates through the following segments: Mobility, Healthcare, Food and Packaging, Base Material, and Others. The Mobility segment covers the new product development support business (solution business) for elastomers, functional compounds, functional polymers, polypropylene compounds, automobiles and other industrial products. The Healthcare segment includes vision care material, non-woven fabric, dental material, and personal care material. The Food and Packaging segment handles the coating and functional materials, functional films and sheets, and agricultural chemicals. The Base Material segment covers the ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, high-purity terephthalic acid, PET resins, polyurethane materials, and industrial chemicals. The Others segment comprises of other related businesses. The company was founded on July 1, 1955 and is headquartered in Tokyo, Japan.

Clearant, Inc. produces tissue allograft implants, plasma therapies, blood and recombinant products. The company was founded on April 30, 1999 and is headquartered in Orlando, FL.

Nanjing Winbo Biotechnology Co., Ltd., established on 2018-06-20, Business scope includes biotechnology research and development,Technical Services;Experimental equipment sales,Technical Services,Technology Promotion;medical instruments,Daily necessities,Office Supplies Sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Daiichi Kagaku Yakuhin KK is a Japanese private company located in Tokyo that engages in processing drugs.

Hualan Genetic Engineering Co., Ltd., established on 2013-06-25, Business scope includes research on biological products,to develop,Production,Sales,technology transfer,check,Agent processing service;Biomedical Technology Consulting;Import and export of goods or technology.